+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BPLPHARMA BPLPHARMA

Bharat Parenterals Share Price

₹1,537.55 +9.6 (0.63%)
Near 52W High of ₹1593.95

07 Sep, 2026 4:01 PM (IST)

Bharat Parenterals live price: ₹1,537.55. It opened at ₹1,476 vs previous close ₹1,528; intraday high/low: ₹1,578/₹1,476. The 50 & 200 DMA stand at ₹1,427.10/₹1,301.30.

Bharat Parenterals Performance

  • Today's Low
  • ₹1,476
  • Today's High
  • ₹1,578
  • 52 Week Low
  • ₹880
  • 52 Week High
  • ₹1,594
  • Open Price₹1,476
  • Previous Close₹1,528
  • Volume1,134
  • 50 DMA₹1,427.10
  • 100 DMA₹1,363.50
  • 200 DMA₹1,301.30

Bharat Parenterals Chart

Investment Returns

  • Over 1 Month + 8.33%
  • Over 3 Month + 12.95%
  • Over 6 Month + 44.22%
  • Over 1 Year + 12.15%

Smart Investing Starts Here Start SIP with Bharat Parenterals for Steady Growth!

Invest Now

Bharat Parenterals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -68.8
  • PEG Ratio
  • -36.4
  • Market Cap Cr
  • 1,060
  • P/B Ratio
  • 3.3
  • Average True Range
  • 76
  • EPS
  • -22.3
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 38.1
  • RSI
  • 61.02
  • MFI
  • 91.37

Latest Stock News Updates

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.

Bharat Parenterals Ltd - 541096 - Intimation Under Regulation 36 Of The SEBI (LODR) Regulations, 2015.

Please find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.

Bharat Parenterals Ltd - 541096 - Reg. 34 (1) Annual Report.

Annual Report for the Financial Year 2025-26

Bharat Parenterals Financials

Bharat Parenterals Technicals

EMA & SMA

Current Price
₹1,537.55
+ 9.6 (0.63%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,477.30
  • 50 Day
  • ₹1,427.10
  • 100 Day
  • ₹1,363.50
  • 200 Day
  • ₹1,301.30

Resistance and Support

1530.45 Pivot Speed
  • R3 1,686.60
  • R2 1,632.20
  • R1 1,584.80
  • S1 1,483.20
  • S2 1,428.80
  • S3 1,381.40

Bharat Parenterals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-05 Quarterly Results & A.G.M.
2026-05-18 Audited Results & Final Dividend
2026-01-30 Quarterly Results
2025-11-12 Quarterly Results
2025-07-28 Quarterly Results & A.G.M.
Date Purpose Remarks
2026-09-12 FINAL Rs.1.00 per share(10%)Final Dividend
2025-09-19 FINAL Rs.1.00 per share(10%)Final Dividend
2024-06-25 FINAL Rs.1.00 per share(10%)Final Dividend
2023-09-25 FINAL Rs.0.75 per share(7.5%)Final Dividend
View Bharat Parenterals Dividend History Arrow

Bharat Parenterals Shareholding Pattern

67.2%
31.31%
1.38%
0.11%

About Bharat Parenterals

Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India. View More
  • NSE Symbol
  • BPLPHARMA
  • BSE Symbol
  • 541096
  • ISIN
  • INE365Y01019

Similar Stocks to Bharat Parenterals

Bharat Parenterals FAQs

Bharat Parenterals share price is ₹1,537 As on 07 September, 2026 | 19:43

The Market Cap of Bharat Parenterals is ₹1059.7 Cr As on 07 September, 2026 | 19:43

The P/E ratio of Bharat Parenterals is -68.8 As on 07 September, 2026 | 19:43

The PB ratio of Bharat Parenterals is 3.3 As on 07 September, 2026 | 19:43

The 52 week High & Low of Bharat Parenterals is ₹1594/₹880.2 respectively As on 07 September, 2026 | 19:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23